Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.50 Contact Hours.

Acknowledgment of Support

This activity is supported by educational grants from Galderma and Sun Pharmaceutical Industries Inc.

Medical Crossfire®: Evaluating Recent Advancements in the Management of Acne Vulgaris

Release Date: October 19, 2020
Expiration Date: October 19, 2021

Activity Overview

The Medical Crossfire®, one of PER®’s signature educational formats, is a video-based program in which a panel of distinguished experts engage in spirited discussions and debates on a particular clinical topic. In this activity, 3 key thought leaders explore the latest data regarding current and emerging therapeutic strategies for the management of acne vulgaris. This lively discussion will help place new developments into clinical context to help optimize patient care.

Acknowledgement of Commercial Support

This activity is supported by educational grants from Galderma and Sun Pharmaceutical Industries Inc.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

This online educational activity is directed toward dermatologists, nurse practitioners, physician assistants, and primary care physicians. Additional health care professionals who are involved in the care of patients with acne will also be invited to participate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Review safety and efficacy of available therapies and their place in the management of acne vulgaris
  • Identify challenges in the management of acne vulgaris and discuss how recently approved therapies help overcome these challenges
  • Assess recent advances in the management of acne vulgaris
  • Utilize tools and resources to optimize outcomes for patients affected by acne vulgaris

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.


Hilary Baldwin, MD
Hilary Baldwin, MD
Clinical Associate Professor of Dermatology
Rutgers Robert Wood Johnson Medical School
New Brunswick, NJ
Medical Director, Acne Treatment & Research Center
Brooklyn, NY

Disclosures: Consultant and Speakers Bureau: Galderma, Foamix Pharmaceuticals, EPI Health, Ortho Dermatologics, Almirall, Mayne Pharma, Journey Medical Corporation, Sol-Gel, Sun Pharmaceutical Industries Inc.

Linda Stein Gold, MD
Linda Stein Gold, MD
Director of Clinical Research
Department of Dermatology
Henry Ford Health System
Division Head of Dermatology
Henry Ford Health System
West Bloomfield, MI

Disclosures: Grant Research Support and Consultant: Galderma, Ortho Dermatologics, Foamix Pharmaceutical, Sol-Gel, Cassiopea, Almirall, Sun Pharmaceuticals; Speakers Bureau: Galderma, Ortho Dermatologics, Foamix Pharmaceutical, Almirall, Sun Pharmaceutical Industries Inc.

Joshua Zeichner, MD
Joshua Zeichner, MD
Director of Cosmetic and Clinical Research, Department of Dermatology
Mount Sinai Hospital
Associate Professor, Department of Dermatology
Icahn School of Medicine at Mount Sinai
New York, NY

Disclosures: Consultant: Almirall, Galderma, Johnson & Johnson, Journey Medical Corporation, L’Oréal, Ortho Dermatologics, Sun Pharmaceuticals, Unilever; Speakers Bureau: AbbVie, Foamix Pharmaceutical, Ortho Dermatologics, Pfizer, Regeneron, Sanofi Genzyme, Sun Pharmaceuticals.

The staff of Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By